IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Poland

  • ID: 1408492
  • Report
  • Region: Poland
  • 54 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

Poland

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Health Insurance
  • Primary and Secondary Care

2. Pricing

  • Prescription Drugs
  • Applications
  • Price Negotiations
  • Listing Agreements
  • “Ex-officio” Pricing Procedure
  • Generic Drugs
  • Hospital Drugs
  • Reference Reimbursement Prices
  • Tenders
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Applications
  • Process
  • Decision
  • Listing Agreements
  • Reimbursement List
  • Timelines
  • Appeals
  • Drug Programmes
  • Chemotherapy Programmes
  • “Ex-officio” Reimbursement
  • Proposed Emergency Reimbursement Pathway
  • Non-reimbursed Drugs
  • Reimbursement Categories
  • Reimbursement Levels
  • Special Reimbursement for Older Patients
  • Reimbursement Channels
  • Reimbursement Prices
  • Reference Price Groups
  • Reference Prices
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • End of Reimbursement Period
  • Expiry of Patent
  • Delistings
  • Reimbursement List Updates
  • “Ex-officio” Delisting
  • Changes in Reimbursement Prices
  • Price Increases
  • Price Reductions
  • Reimbursement Reviews
  • Reimbursement List Updates

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • Information Requirements
  • Evaluation
  • Controversy

5. Price Build Up

  • Wholesalers
  • Margins
  • Background
  • Shortages
  • Monitoring
  • Retail Pharmacies
  • Margins
  • Background
  • Mail-order/E-pharmacy
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Expenditure
  • Advertising
  • Patient Co-payments
  • Pharmaceuticals
  • Primary and Secondary Care
  • Prescribing Controls
  • Prescribing Regulations
  • Monitoring
  • Other Controls
  • Prescribing Rights
  • Generics
  • Generic Substitution
  • INN Prescribing
  • Pharmacy Margins
  • Rx-to-OTC Switches
  • Parallel Trade
  • Parallel Imports
  • Parallel Exports

7. Future Developments

  • Outlook
  • Abolition of the NFZ
  • Overhaul of the Hospital Sector
  • Reform of Primary Care
  • Emergency Access to Non-reimbursed Medicines
  • Reimbursement Reforms
  • Healthcare Budget
  • Changes to Pharmacy Regulations
  • Monitoring System for Medical Products
  • Office of Public Health

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll